MoA

Product Family

Our technology is designed to enable clinicians to apply thermotherapy treatment to the precise site of the tumor.

The Sensius system is a technology platform. With the system, different body site applicators will be available in the future. The body applicators can be connected to the FocusCore, that produces the microwaves. The body applicator directs the microwaves to the tumor by the antennas in the applicator, which are controlled by the FocusControl software. 

The first applicator is for the treatment of Head and Neck Cancer. A prototype is already in use in Erasmus MC (Rotterdam, NL). The prototype is now in the transition to a commercial product. We aim for market launch early 2024.

The second applicator is for the treatment of intact breast cancer. This will be released early 2025 for clinical evaluation.

In addition, our technology is also made to optimize the treatment outcome and enables a choice to balance the outcome and quality of life.

MoA

Currently, Sensius’ Focus product family consists of different components

Screenshot 2021 11 25 at 15.34.59

FocusCore

A a base unit which comprises all components which are needed for treatment of all type of tumours (including a height-adjustable bed, twenty independently controlled microwave amplifiers, water pumps and cooling, a nurse station and control computers). No extra room is needed for the amplifiers.

Screenshot 2021 11 25 at 15.34.49

FocusCollar

A body-site specific add-on to our FocusCore to position antennas around the target area and connect the energy to the body via a body-site specific bolus, such as the FocusCollar for head and neck cancer.

Screenshot 2021 11 25 at 15.35.52

FocusControl

A software providing accurate treatment preparation and delivery, customized to individual patient. Based on our WaveAdaptstm patented technology.